Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 14,502 | 10,869 | 10,338 | 11,198 | 10,354 |
| Operating Income | -14,502 | -10,869 | -10,338 | -11,198 | -10,354 |
| Other Income | -30,405 | -12,762 | -19,761 | 1,292 | -55,406 |
| Pre-tax Income | -44,907 | -23,631 | -30,099 | -9,906 | -65,760 |
| Net Income Continuous | -44,907 | -23,631 | -30,099 | -9,906 | -65,760 |
| Net Income | $-44,907 | $-23,631 | $-30,099 | $-9,906 | $-65,760 |
| EPS Basic Total Ops | -0.92 | -0.65 | 0.08 | -0.33 | -2.74 |
| EPS Basic Continuous Ops | -1.06 | -0.79 | -0.91 | -0.33 | -2.74 |
| EPS Diluted Total Ops | -0.92 | -0.65 | 0.08 | -0.33 | -2.74 |
| EPS Diluted Continuous Ops | -1.06 | -0.79 | -0.91 | -0.33 | -2.74 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.34 | -0.29 | N/A | N/A |
| EBITDA(a) | $-14,502 | $-10,869 | $-10,244 | $-11,007 | $-10,357 |